These results indicated that Leo was effective in alleviating the abnormalities in the T, LH, and FSH levels and follicle development in PCOS mice, suggesting that this treatment improved these parameters in mice with DHEA-induced PCOS. Here, PLOD1 is linked to polycystic ovary syndrome.